Member Info for Tillywhiz

Evening investors

Below paragraph sums up recent RNS & underpinned by prevail -

As 2024 unfolds, Hemogenyx anticipates starting clinical trials and advancing its CBR platform towards IND-enabling studies, signaling a landmark year with promising outcomes for investors and patients alike..

👍 superb last line for all invested & patients in the future -

Always get your doommongers loitering on forums on stocks with potential , likely buying stock when shovelling doom dung on the forum , in my experience,

Imo - The stock price will re rate & the Grog will flow in investors tankards

Hemo on Ortex - very positive

& when you include Vlads recent interview- transformational yr for Hemo & investors

Hemogenyx Pharmaceuticals achieves breakthrough with HEMO-CAR-T program, CBR platform

(via NewsDirect)

Hemogenyx Pharmaceuticals PLC CEO Dr Vladislav Sandler and non-executive director Peter Redmond joined Proactive's Stephen Gunnion after the company pioneering breakthrough treatments for life-threatening diseases, including blood and solid cancers, achieved a number of significant milestones.

Sandler highlighted the company's significant progress with its HEMO-CAR-T program after it received the green light from the US Food and Drug Administration (FDA) to enter Phase 1 clinical trials for acute myeloid leukaemia, marking its transition to a clinical-stage biopharmaceutical company. This development symbolises a pivotal milestone, offering potential life-changing treatments for patients with limited options.

Additionally, Hemogenyx is advancing its proprietary Chimeric Bait Receptor (CBR) platform, announcing that it has demonstrated in vivo that the CBR can be delivered intranasally in the form of messenger RNA (mRNA) for the potential treatment of airborne viral infections.

As 2024 unfolds, Hemogenyx anticipates starting clinical trials and advancing its CBR platform towards IND-enabling studies, signaling a landmark year with promising outcomes for investors and patients alike..

👍 superb last line for all invested & patients in the future -

Always get your doommongers on stocks loitering on forums , likely buying when dooming in my experience.

Imo - The stock price will re rate & the Grog will flow in investors tankards

HT & all

I hear Prevail Rocket Fuel gives a decent boost

Morning majority

Looking forward to coming months , irrespective of recent market shenanigans, just re read the last 3 RNS & listen to Vlads latest interview all positive & of course Prevail stood underpinning potential science deals .

As noted on Ortex yesterday a very positive quote ;

As 2024 unfolds, Hemogenyx anticipates starting clinical trials and advancing its CBR platform towards IND-enabling studies, signaling a landmark year with promising outcomes for investors and patients alike..

Grog will eventually flow for all invested .

Afternoon all - Hemo on Ortex - positive read for sure .

Hemogenyx Pharmaceuticals achieves breakthrough with HEMO-CAR-T program, CBR platform

(via NewsDirect)

Hemogenyx Pharmaceuticals PLC CEO Dr Vladislav Sandler and non-executive director Peter Redmond joined Proactive's Stephen Gunnion after the company pioneering breakthrough treatments for life-threatening diseases, including blood and solid cancers, achieved a number of significant milestones.

Sandler highlighted the company's significant progress with its HEMO-CAR-T program after it received the green light from the US Food and Drug Administration (FDA) to enter Phase 1 clinical trials for acute myeloid leukaemia, marking its transition to a clinical-stage biopharmaceutical company. This development symbolises a pivotal milestone, offering potential life-changing treatments for patients with limited options.

Additionally, Hemogenyx is advancing its proprietary Chimeric Bait Receptor (CBR) platform, announcing that it has demonstrated in vivo that the CBR can be delivered intranasally in the form of messenger RNA (mRNA) for the potential treatment of airborne viral infections.

As 2024 unfolds, Hemogenyx anticipates starting clinical trials and advancing its CBR platform towards IND-enabling studies, signaling a landmark year with promising outcomes for investors and patients alike..

👍 superb last line for all invested & patients in the future -

Imo - The stock price will re rate & the Grog will flow in investors tankards

Hemogenyx Pharmaceuticals PLC Announces CBR Brain Delivery

Accesswire 18th

Chimeric Bait Receptors for Combatting Brain Cancers and Neurodegenerative Diseases Can Be Delivered via Programmed Microglial Cells

LONDON, UK / ACCESSWIRE / February 16, 2024 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the clinical stage biopharmaceutical group, announces that it has demonstrated in vivo that its proprietary Chimeric Bait Receptor ("CBR") can be delivered into the brain via programmed microglial cells for the potential treatment of brain cancers and certain neurodegenerative diseases.

Delivery of therapeutics across the blood-brain barrier is one of the most difficult problems in the treatment of brain cancers and certain neurodegenerative diseases. Our scientists at have developed a method of transplantation of human hematopoietic (blood) stem cells ("HSC") that allows their engraftment and differentiation into microglial cells (immune cells that reside in the brain) in the brains of immune-compromised mice.

The Company believes that autologous HSCs that are genetically modified to make CBR and transplanted back to a patient could give rise to microglial cells in the patient's brain. Such microglial cells that have been armed with CBR could potentially be able to find and phagocytose (ingest and destroy) either brain cancer cells or abnormal protein aggregations (e.g., amyloid plaques in Alzheimer's).

The Company's approach described above may offer a number of benefits: (1) it could deliver CBR therapeutics across the blood brain barrier; (2) CBR-armed microglial cells may not be rejected as they are autologous/patient-derived; (3) CBR-armed microglial cells may provide long-term protection of the brain against cancer or protein aggregations because microglial cells live for a long time; and (4) autologous HSC, which are self-renewing, could become an almost unlimited source of CBR-armed microglial cells for the patient.

This is a further indication of the growing range and versatility of CBR as a potential tool against a variety of difficult to treat and deadly conditions.

Research continues on CBR and the Company intends to increase its focus on this once HEMO-CAR-T has entered clinical trials.

Dr Vladislav Sandler, CEO & Co-Founder of Hemogenyx Pharmaceuticals, commented: "This major breakthrough in the method of delivery of our CBR into the brain is a unique tool that may allow us to successfully tackle some of the most difficult and often incurable human diseases. As we broaden the scope of use for our CBR platform, we are eager to continue its development."

Morning all

RNS = flat

No RNS = + 20% 😂

Bring on the Pharma Deals Prevail

Evening all

Looking forward to coming weeks , irrespective of recent market shenanigans, just re read the last 3 RNS & listen to Vlads latest interview all positive & of course Prevail stood underpinning potential science deals .

Delayed reaction on stock news , perhaps or further news .

Orph & all

Morning ,

Certainly some market shenanigans of late , 3 cracking RNS yet in the 3s

Always sceptical on the markets , & was indeed a seller loitering in the shadows & the Ai bots in charge of trading .

Shorts only rose minimum & small %

The 6 month graph still looks very positive irrespective of recent reversal , heading in a north trajectory since Prevail got involved .

With these recent positive RNS & more in the pipeline on partnerships/ funding etc + Vlads interview , next few weeks / months could certainly be interesting for investors .

Any whiff of a large pharma involved / offer etc & stock price will be in double digits imo

Just patience required .

Fetch the Full English to soak up the Grog

Been on the grog ,

It’s been a superb week for RNS for Hemo investors & even better to come with Prevail pushing the financial buttons !

Unfortunately, not a great week for a mate of mine Randy Rick who got his sleeping tablets & Viagra mixed up & ended up having forty w.a.n.ks Ha ha 🤣

Just some grog fuelled humour after a great week on news ,

Morning all invested

Been a great week for RNS for Hemo & all invested

& some great info/ opinion posted from many on this forum .

Recent RNS

. CBR - Brain delivery

.CBR - intranasal delivery

.CAR T - clinical confirmed & underpinned via Prevail

Interview with Vlad also very positive & certainly cranking up what Hemo has to offer .

Hopefully a pharma deal of some sort , partnership, investment, or full buy out , on CAR T or CBR in the pipeline .

The markets will eventually re rate the stock for all invested .

Have a great weekend all & looking forward to coming months .

Closing Price 3.22 UT

Vol 19.7 million

Vwap 3.32

Auto vol 13 million

A superb week for RNS ,

3 x crackers in last 2 weeks , & Hemo multi pronged science unfolding

Stock price will follow eventually…

Have a great weekend all invested

A big bag of kippers - buys some delayed just been tossed on deck by the robots

16-Feb-24 15:48:05 3.267 300,000 Buy* 3.21 3.27 9,801 O

16-Feb-24 15:48:05 3.267 300,000 Buy* 3.21 3.27 9,801 O

16-Feb-24 14:32:15 3.271 455,974 Unknown* 3.21 3.27 14.91k O

16-Feb-24 15:25:52 3.26 113,621 Buy* 3.20 3.26 3,704 A

16-Feb-24 15:25:43 3.2646 332,071 Buy* 3.20 3.26 10.84k O

Algos in charge of trading working the buy /sell orders within the spread

1.3 million auto vol

MrI & all

Tend to agree on the algo front ,as I’ve said before all seems very organised & orchestrated / controlled almost robotic

Algorythmic trading etc

Auto vol has been high 1m + for last few sessions .

Anyhow been a good week on the RNS front , stock price will follow once robots have had there party .

Bline & all

Agree with that dude ,

Hemos multi pronged science finally baring fruit

With that & the interview JFTH posted looks like a transformational yr for Hemo & investors imo

Fetch the Friday Grog

Monkey & all

So let me get this straight,

Your not & haven’t even been invested in Eua or Hemo yet telling others not to post there style because you don’t like it as your a Good Samaritan

You reek of agenda pal

I don’t post to encourage anyone to sell or buy , just post my position with humour .

Hemo numbers on Ortex - For anyone interested

Hemogenyx Pharmaceuticals, under the ticker HEMO, has notably deviated from the average movement of its peers in the biotech sector with a last month surge of 31.43%.

The trading volume for the last day clocked in at 9,355,219 shares, marginally higher by 3.03% than the three-month average.

Despite a recent downturn with a 7-day price performance dip of -21.28%, the Year-To-Date price change registers a significant rise of 33.48%.

The current Relative Strength Index (RSI) stands at 57.61.

Current stock 3.25 +6%

Volume 14.5 million

Vwap 3.35

Spread 6%

Auto vol 780 k

You still at it monkey

You come on here nibbling my ass I will react , this the Hemo forum keep it to this

Strange as I never saw you on that forum when the stock was high or for that matter on this forum & I’ve been here yrs .

I sold stock on EUA when the war started & noted it on the forum it covered all my costs & still hold stock for potential asset sale .( remember the Russian war )

The only posters on that forum moaning about my humour & info posted are the wannabe wolf of wall st s that lack self responsibility & ooze toxicity.

Perhaps take some responsibility for your own investment decisions & stop bleating in my lug hole .

To add for monkey & all

Why didn’t you buy in here @ 1p or Eua at 0.8 p as I did at points

Plenty of opportunities to sell at a profit on both

If I buy stock on any share based on what I read on these chat forums that would be my responsibility, & I would do my own research .

Why don’t you do some research & grow a pair instead of blaming others for your poor timing as a trader .

These boards are awash with wolf of wall st wannabes that only made Mudskipper of bog st